BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15989944)

  • 1. Life, death, and ubiquitin: taming the mule.
    Shmueli A; Oren M
    Cell; 2005 Jul; 121(7):963-5. PubMed ID: 15989944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis.
    Zhong Q; Gao W; Du F; Wang X
    Cell; 2005 Jul; 121(7):1085-95. PubMed ID: 15989957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
    Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
    Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BH3-ligand regulates access of MCL-1 to its E3 ligase.
    Warr MR; Acoca S; Liu Z; Germain M; Watson M; Blanchette M; Wing SS; Shore GC
    FEBS Lett; 2005 Oct; 579(25):5603-8. PubMed ID: 16213503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The double life of MULE in preeclamptic and IUGR placentae.
    Rolfo A; Garcia J; Todros T; Post M; Caniggia I
    Cell Death Dis; 2012 May; 3(5):e305. PubMed ID: 22552282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EEL-1 ubiquitin ligase promotes DNA damage-induced germ cell apoptosis in C. elegans.
    Ross AJ; Li M; Yu B; Gao MX; Derry WB
    Cell Death Differ; 2011 Jul; 18(7):1140-9. PubMed ID: 21233842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 ubiquitination: Mdm2 and beyond.
    Brooks CL; Gu W
    Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.
    Inoue S; Hao Z; Elia AJ; Cescon D; Zhou L; Silvester J; Snow B; Harris IS; Sasaki M; Li WY; Itsumi M; Yamamoto K; Ueda T; Dominguez-Brauer C; Gorrini C; Chio II; Haight J; You-Ten A; McCracken S; Wakeham A; Ghazarian D; Penn LJ; Melino G; Mak TW
    Genes Dev; 2013 May; 27(10):1101-14. PubMed ID: 23699408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of apoptosis: the ubiquitous way.
    Yang Y; Yu X
    FASEB J; 2003 May; 17(8):790-9. PubMed ID: 12724336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced association of anti-apoptotic protein Mcl-1 with E3 ligase Mule increases the stability of Mcl-1 in breast cancer cells.
    Pervin S; Tran A; Tran L; Urman R; Braga M; Chaudhuri G; Singh R
    Br J Cancer; 2011 Jul; 105(3):428-37. PubMed ID: 21730980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction.
    Gomez-Bougie P; Ménoret E; Juin P; Dousset C; Pellat-Deceunynck C; Amiot M
    Biochem Biophys Res Commun; 2011 Sep; 413(3):460-4. PubMed ID: 21907705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
    Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
    J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site.
    Warr MR; Mills JR; Nguyen M; Lemaire-Ewing S; Baardsnes J; Sun KL; Malina A; Young JC; Jeyaraju DV; O'Connor-McCourt M; Pellegrini L; Pelletier J; Shore GC
    J Biol Chem; 2011 Jul; 286(28):25098-107. PubMed ID: 21613222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.
    Cai QL; Knight JS; Verma SC; Zald P; Robertson ES
    PLoS Pathog; 2006 Oct; 2(10):e116. PubMed ID: 17069461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
    Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.
    Qi CF; Kim YS; Xiang S; Abdullaev Z; Torrey TA; Janz S; Kovalchuk AL; Sun J; Chen D; Cho WC; Gu W; Morse Iii HC
    Int J Mol Sci; 2012; 13(5):6204-6219. PubMed ID: 22754359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential Roles of E3 Ubiquitin Ligases in p53 Regulation.
    Sane S; Rezvani K
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mcl1 becomes ubiquitin-ous: new opportunities to antagonize a pro-survival protein.
    Hogarty MD
    Cell Res; 2010 Apr; 20(4):391-3. PubMed ID: 20357805
    [No Abstract]   [Full Text] [Related]  

  • 19. Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53.
    Duan S; Yao Z; Hou D; Wu Z; Zhu WG; Wu M
    EMBO J; 2007 Jul; 26(13):3062-74. PubMed ID: 17568776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.
    Weger S; Hammer E; Heilbronn R
    FEBS Lett; 2005 Sep; 579(22):5007-12. PubMed ID: 16122737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.